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Biotin Interference and Laboratory
Testing: Possible Implications/
Ramiﬁcations for Emergency Medicine
To the Editor:
Biotin (also known as vitamin B7 or vitamin H)
interference in clinical immunoassays has been reported to alter
results for some patients.1 There are very few laboratory and
clinical studies determining the magnitude, the necessity of
addressing this issue, or the development of recommendations
on how to manage the potential risk of biotin interference in
laboratory testing. Physicians, unless otherwise warned, expect
all laboratory test results to be accurate for optimal patient
management. When unrecognized erroneous results are
reported to them, misdiagnoses with resultant clinical
mismanagement of patients can occur.
Biotin levels higher than those observed with the normal
dietary intake of biotin-rich foods can interfere with
troponin, human chorionic gonadotropin, thyroidstimulating hormone, and other laboratory results.
Speciﬁcally, this interference has resulted in misdiagnoses
and mistreatment of heart disease, thyroid conditions,
breast cancer, pregnancy, and fertility, with associated
increases in adverse advents and one death.2-4
Supplemental biotin is consumed by many individuals
wishing to improve their hair, nail, and skin health and
beauty, by expectant mothers for better fetal development,
and as therapeutic treatments for patients with multiple
sclerosis, dermatitis, diabetes, and other chronic illnesses.
The Food and Nutrition Board at the National Academies of
Sciences, Engineering, and Medicine has established the
adequate intake for adults (not a daily recommended
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amount) as 30 mg for men and women. There is no evidence
that daily dosages of this amount interfere with testing.
However over-the-counter biotin supplements can contain
up to 10 mg of biotin, leading to concentrations in the blood
at which interference in laboratory testing can occur.
The Mayo Clinic reported from an outpatient survey sent
to 4,000 individuals, of which 1,944 were completed and
returned. It showed that 7.7% of individuals (79.2%
women, 20.8% men) used multivitamin or biotin
supplements. Also, the authors reported that quantiﬁcation
of biotin in residual waste plasma samples (1,442) from
emergency department patients that were sent for electrolyte
analysis revealed that 737 (51.1%) contained biotin levels
less than 5 ng/mL; 598 (41.5%), 5 to 9 ng/mL; 100 (6.9%),
10 to 29 ng/mL; and 7 (0.4%), greater than 30 mg/mL. At
concentrations greater than 10 ng/mL (7.4% of samples
measured), biotin could cause interference in some
laboratory tests. Chart review of these patients indicated that
1.9% of these patients had biotin and 30.8% had
multivitamins listed in their medical records.5
Given the increase in both biotin supplement use and
the percentage of patients with higher biotin blood levels
that may interfere with the accuracy of laboratory testing
results, patients and physicians must be made aware of this
potential problem. Emergency physicians, hospitalists,
laboratorians, and the manufacturers of testing equipment
should initiate further clinical studies of biotin interference
in laboratory testing. Speciﬁcally, these efforts should
include reviewing all laboratory tests that use technology
potentially affected by the presence of biotin in blood
samples, developing methods to determine the amount of
biotin present (emergency physicians cannot accurately
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estimate this based on patient history), and, if the levels are
high, providing an accurate possible conversion or
substituting an alternative reliable test.
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To the Editor:
There has been signiﬁcant discussion about the
management of critically ill patients with coronavirus disease
2019 (COVID-19). We share concerns with many of our
colleagues about the potential for airborne spread of the virus

Figure 1. Aerosol hood design and proper application.

370 Annals of Emergency Medicine

Volume 76, no. 3 : September 2020

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on October 20, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.

